Drug intelligence / Profile preview

Peifeikang

Development stage: Unknown
Lead developer: Shanghai Sine
Modality: Live Biotherapeutic Products → Microbiome Therapeutics
Administration: Oral

Overview

Peifeikang is a probiotic pharmaceutical product composed of three live bacterial strains: *Bifidobacterium longum*, *Lactobacillus acidophilus*, and *Enterococcus faecium*. It is widely used in China for the treatment of intestinal dysbiosis and related gastrointestinal conditions, including acute and chronic diarrhea, constipation, and abdominal distension. The formulation works by replenishing beneficial gut flora, inhibiting the growth of pathogenic bacteria, and restoring the ecological balance of the intestinal tract. Beyond its established gastrointestinal indications, Peifeikang is being investigated by researchers at West China Hospital for its potential to modulate the gut-brain axis in patients with refractory epilepsy, aiming to reduce seizure frequency by influencing systemic inflammation and neurotransmitter production.

Brand names: PeifeikangBIFIDOBI
Other names: Bifidobacterium, Lactobacillus, and Enterococcus Capsules, Triple Live BacteriaBifidobacterium Triple Live Bacteria CapsulesBifidobacterium longum + Lactobacillus acidophilus + Enterococcus faecium

Beyond the preview

Go deeper on Peifeikang.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Peifeikang.

Explore the full profile